RxDoctor Payments Data

Matthew Swiatowicz, PA

Physician Assistant · Jacksonville, FLNPI 1801150594

Payments from drug & device makers

$11,087in general payments, 2019–2025

Across 618 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Insulet Corporation$1K
  • Abbott$970
  • Amgen$767
  • Sanofi-aventis U.S. LLC$703
  • Dexcom, Inc.$677
  • plus $5K from 41 others

What the payments were for

  • Food & beverage$11,087100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,087 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$112,905
Medicare patients
449
Services billed
2,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide360$604,481
MounjaroTirzepatide195$313,882
JardianceEmpagliflozin184$228,196
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog111$158,432
FarxigaDapagliflozin Propanediol122$144,083
Tresiba Flextouch U-200Insulin Degludec69$97,872
TrulicityDulaglutide66$95,981
Synjardy XrEmpagliflozin/Metformin Hcl66$93,142
Soliqua 100-33Insulin Glargine/Lixisenatide50$87,546
Humulin R U-500Insulin Regular, Human23$68,749
Tresiba Flextouch U-100Insulin Degludec70$51,752
JanuviaSitagliptin Phosphate40$48,797
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/745$48,008
Xigduo XrDapaglifloz Propaned/Metformin28$44,563
ProliaDenosumab23$40,389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$1,333$647,803400 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$612$432,418332 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$462$339,113262 claims
AstraZenecaFarxiga$555$144,083122 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$703$87,54650 claims
MerckJanuvia$115$48,79740 claims
AmgenProlia$767$40,38923 claims
AbbVieSynthroid$232$11,626136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →